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Abstract
Background:  Male infertility is a major problem for mammalian reproduction. However,
molecular details including the underlying mechanisms of male fertility are still not known. A
thorough understanding of these mechanisms is essential for obtaining consistently high
reproductive efficiency and to ensure lower cost and time-loss by breeder.
Results: Using high and low fertility bull spermatozoa, here we employed differential detergent
fractionation multidimensional protein identification technology (DDF-Mud PIT) and identified 125
putative biomarkers of fertility. We next used quantitative Systems Biology modeling and canonical
protein interaction pathways and networks to show that high fertility spermatozoa differ from low
fertility spermatozoa in four main ways. Compared to sperm from low fertility bulls, sperm from
high fertility bulls have higher expression of proteins involved in: energy metabolism, cell
communication, spermatogenesis, and cell motility. Our data also suggests a hypothesis that low
fertility sperm DNA integrity may be compromised because cell cycle: G2/M DNA damage
checkpoint regulation was most significant signaling pathway identified in low fertility spermatozoa.
Conclusion: This is the first comprehensive description of the bovine spermatozoa proteome.
Comparative proteomic analysis of high fertility and low fertility bulls, in the context of protein
interaction networks identified putative molecular markers associated with high fertility phenotype.
Background
Male infertility is a major problem for mammalian repro-
duction. The nature of sub-fertility due to the male is as
complex as that of the female [1]. Infertility due to male
factor contributes approximately 40% of the infertility
cases in humans. For this reason it is very important to
investigate the factors that affect male fertility. Here we
used bovine spermatozoa to model human male fertility
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because cattle provide several advantages as a model for
male factor infertility. These include good breeding
records fertility data records and progeny records. In cattle
breeding, Artificial insemination (AI), a common breed-
ing technique, utilizes semen from genetically superior
sires to inseminate cows. In the United States more than
~70% of cows are bred by AI but only ~50% of these mat-
ings result in successful full term pregnancy [2]. The
underlying molecular events/mechanisms that determine
the fertilizing potential of a semen sample are not well
defined. A thorough understanding of these mechanisms
is essential for obtaining consistently high reproductive
efficiency and to ensure lower cost and time-loss by
breeder.
Fertility traits of semen can be categorized as compensable
or uncompensable [1,3-7]. Defects in compensable traits
(motility and morphology) can be overcome by increas-
ing the number of spermatozoa per insemination [1].
Defects in uncompensable traits affect the function of
spermatozoa during the later stages of fertilization and in
embryonic development [1,8] and as such cannot be com-
pensated. Uncompensable traits include nuclear vacuoles
[9], morphological deficiencies that do not suppress
movement [4], defective chromatin structure [10]. Low
fertility in bulls has an uncompensable component that
includes reduced cleavage rate and delayed pronuclear
formation following in vitro fertilization [1,11]. Currently
available fertility assays assess the defects that affect func-
tional competence of spermatozoa (i.e. capacitation, acro-
some reaction, sperm-oocyte interaction) [8,12], however
these cannot definitively predict fertility. At present, the
molecular nature of sperm fertility defects or biomarkers
for accurate fertility prediction is not known [13].
Spermatozoa are transcriptionally inactive so the only
comprehensive method to understand the molecular
functions in spermatozoa is via proteomics [13]. Pub-
lished proteomic studies with bull spermatozoa described
the sub-proteome of the sperm and functions of proteins
from its surrounding cells. Accessory gland (AG) proteins
were shown to modulate important sperm functions after
ejaculation and in the female reproductive tract such as
capacitation, acrosome reaction, sperm-oocyte interac-
tion, and sperm protection [14]. It is known that fertile
associated antigen (FAA), a heparin binding protein from
seminal vesicles and prostate glands, binds to spermato-
zoa membrane and modulates heparin-sperm interac-
tions that are indicative of fertility [15]. Two seminal
plasma proteins such as, prostaglandin-D-synthetase and
osteoponin were more abundant in the semen of high fer-
tility bulls when compared to low fertility bulls [16,17].
Here we describe a comprehensive proteomic analysis of
bull sperm using differential detergent fractionation
(DDF) two-dimensional liquid chromatography followed
by electrospray ionization tandem mass spectrometry
(DDF 2-LC ESI MS2; [18]). We compared protein expres-
sion profiles of sperm from high and low fertility bulls to
characterize the differences in fertility at the protein level.
Our results show that expression of 2051 and 2281 pro-
teins was specific to high and low fertility bull spermato-
zoa, respectively and 1518 proteins were common to
both. Differential expression of 125 proteins was signifi-
cant between high and low fertility bull spermatozoa and
these proteins are potential biomarkers for bovine male
fertility. Biological systems utilize highly complex, interre-
lated metabolic and signaling pathways to function.
Therefore, to identify signaling pathways involved in fer-
tility, we carried out systems modeling of our proteomic
datasets using Gene Ontology (GO) and Ingenuity Path-
way Analysis (IPA). We identified differences in the sign-
aling pathways between high and low fertility bull
spermatozoa and found that EGF and PDGF signaling
pathways were specific to high fertility.
Results
Proteome profiles of spermatozoa from high and low 
fertility bulls
We identified 3569 and 3799 proteins in high and low fer-
tility group spermatozoa respectively (see additional file
1). Among these 1518 (20.4%) were common to both
groups and 2051 and 2281 proteins were unique to high
and low fertility groups respectively (Figure 1). Only those
proteins identified by at least three peptides were included
in the analysis for differential expression and we identi-
fied 125 proteins as differentially-expressed between the
high and low fertility spermatozoa. Compared to low fer-
tility bull spermatozoa, expression of 74 proteins
increased and there was a decrease in the expression of 51
proteins in high fertility spermatozoa (Table 1). Only a
small proportion of proteins identified in this study have
been previously described (15.1% of the high fertility
group specific and 14.3% of the low fertility group specific
proteins (Figure 1)). The majority of the identified pro-
teins are 'predicted' (i.e. predicted based on sequence sim-
ilarity to known proteins in other species and are
frequently found in NRPD database for species that have
had their genomes sequenced [19]). We contributed to
the annotation of the newly sequenced bovine genome by
experimentally confirming the in vivo expression of 4,313
electronically predicted proteins (see additional file 1).
We also identified 10.6% and 9.8% 'hypothetical' (i.e.
proteins predicted from nucleic acid sequences and that
have not been shown to exist by experimental protein
chemical evidence [20]) proteins specific to high fertility
and low fertility spermatozoa respectively.
Predicted and hypothetical proteins do not have any func-
tional annotation associated with them and they repre-BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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sent ~80% of differentially expressed proteins between
high and low fertility spermatozoa (Table 1). This poses a
problem for meaningful biological modeling of our data
without carrying out some functional annotation first.
Therefore, we annotated all differentially expressed pro-
teins in our data sets using AgBase GO resources.
Membrane and nuclear proteins
Membrane and nuclear proteins are fundamental for inter
and intra cellular signaling and are thus fundamental for
modeling cell-cell interactions. Sperm oocyte fusion is a
key element for fertilization. This process is facilitated by
sperm surface proteins and leads to specific binding of the
sperm surface-active component with the egg zona pellu-
cida and, ultimately, sperm-egg fusion [21]. To identify
proteins from the sperm membrane and the nucleus
which function in cell fusion, we focused on membrane
and nuclear proteins identified in our datasets. Based on
the GO associations of known proteins, 40.6% (395) are
membrane proteins. We also identified 112 nuclear pro-
teins based on GO associations. Biological process anno-
tation of membrane proteins revealed that majority of
membrane proteins involved in transport (33%), cell
communication (18%) and metabolism (17%).
We GO annotated all differentially expressed proteins and
applied the generic GO Slim [22] to identify 7 functional
super-categories represented in differentially expressed
proteins in high fertility spermatozoa. Most GO Slim cat-
egories, including processes such as metabolism, cell com-
munication and cell motility showed overall up
regulation of protein expression in the high fertility group
while transport proteins showed an overall down regula-
tion in the high fertility group (Figure 2).
High fertility and low fertility sperm proteomes: molecular 
network and pathway analysis
Protein identification from biological samples on a global
scale is important. However, there is a need to move
beyond this level of analysis; Instead of simply enumerat-
ing a list of proteins, the analysis needs to include their
interactions as parts of complexes, pathways and biologi-
cal networks. To achieve this level of analysis with our
high fertility and low fertility spermatozoa proteomic
datasets we used Ingenuity Pathway Analysis (IPA). At IPA
thresholds for significance, 71, and 73 networks and 68,
and 73 functions/diseases were significantly represented
in the proteomes of high fertility and low fertility sperma-
tozoa respectively. The top 10 functions/diseases (ranked
based on significance), and the associated signaling path-
ways are shown in Table 2 and Table 3 for proteomes of
high and low fertility groups respectively. Analysis of the
top 10 functions revealed that functions like cellular
movement, cell to cell signaling and interaction were
identified only in the high fertility sperm proteome (Table
2). Whereas, functions like cell death and reproductive
system disease were identified only in the low fertility
sperm proteome (Table 3).
Compared to low fertility sperm proteome (9), the high
fertility sperm proteome (20) had a 2-fold enrichment in
signaling pathways. However, the number of significant
Comparison of proteins identified in high fertility and low fertility spermatozoa Figure 1
Comparison of proteins identified in high fertility and low fertility spermatozoa. Distribution of predicted, known 
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Table 1: Differentially expressed proteins.
Accesion Name Peptides ∑Xcorr P-value Regulation
HF LF HF LF
115496714 Actin-like 7B 16 7 60.06 42.11 0.02243 up
77736067 Acyl-CoA thioesterase 9 14 4 39.23 16.48 2.11E-04 up
41386786 A-kinase anchor protein 4 679 581 2581.8 2424.3 0.001694 up
30794280 Albumin 7 1 27.09 5.24 1.49E-04 up
60302887 Aldose reductase 1 3 3.03 12.82 0.03293 down
27807289 Annexin A2 4 10 29.17 26.46 0.04155 down
84490369 ATP synthase, H+ transporting, mitochondrial 16 8 48.01 31.88 0.0333 up
28603752 ATP synthase, H+ transporting, mitochondrial F0 7 1 18.99 7.14 0.005907 up
28461221 ATP synthase, H+ transporting, mitochondrial F1 complex 201 174 765.55 700.71 0.006727 up
28461251 ATPase inhibitory factor 1 precursor 18 10 45.95 30.03 0.01581 up
27807145 Casein kinase 2, alpha prime polypeptide 3 0 11.25 0 5.01E-04 up
60101831 Cytochrome c oxidase subunit III 5 4 17.45 11.47 0.01008 up
84000107 Glycoprotein (transmembrane) nmb 0 3 6.9 8.98 0.0133 down
84000035 Hypothetical protein LOC504736 3 1 8.66 2.04 0.03204 up
115497288 Hypothetical protein LOC506544 4 7 13.54 18.39 0.04931 down
78369248 Hypothetical protein LOC509274 18 10 77.94 51.72 0.01217 up
115496338 Hypothetical protein LOC516024 27 22 109.76 67.93 1.54E-05 up
115495377 Hypothetical protein LOC520260 44 58 201.9 232.07 0.04396 down
114052468 Hypothetical protein LOC532785 8 19 32.19 55.25 0.003313 down
115496742 Hypothetical protein LOC534599 27 11 88.93 61.57 0.02739 up
84000301 Hypothetical protein LOC534927 9 3 32.16 14.67 0.01593 up
115495951 Hypothetical protein LOC540767 20 12 62.88 41.8 0.004421 up
94966950 Hypothetical protein LOC614199 4 0 10.84 1.66 0.007311 up
84000391 Hypothetical protein LOC615316 11 5 35.17 24.34 0.02524 up
115497750 Hypothetical protein LOC617117 19 12 58.06 44.14 0.03432 up
116004271 Hypothetical protein LOC767959 4 0 12.9 3.03 0.04429 up
27805989 Lysyl oxidase-like 4 1 3 1.59 7.16 0.03124 down
27806307 Mitochondrial ATP synthase, O subunit 13 8 51.79 34.78 0.03731 up
28461275 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 13 3 48.9 27.96 0.05046 up
28461255 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 2 4 3.67 13.56 0.01051 down
62751972 Potassium voltage-gated channel shaker-related 3 0 5.86 0 1.21E-04 up
119891540 PREDICTED: glutathione S-transferase kappa 1 3 3 10.97 8.47 0.01147 up
119887606 PREDICTED: hypothetical protein 1 3 2.03 8.02 0.04382 down
119903031 PREDICTED: hypothetical protein 5 15 25.57 46.02 2.23E-04 down
119908822 PREDICTED: hypothetical protein 3 1 7.23 1.65 0.03051 up
119888977 PREDICTED: hypothetical protein 11 3 37.09 22.02 0.03232 up
119905186 PREDICTED: hypothetical protein 0 3 0 6.3 1.90E-05 down
76661674 PREDICTED: hypothetical protein 1 4 2.22 9.87 0.01595 down
119901076 PREDICTED: hypothetical protein 1 5 9.84 11.22 0.04157 down
119918378 PREDICTED: hypothetical protein 3 15 16.31 36.68 5.24E-04 down
61843441 PREDICTED: hypothetical protein 0 4 0 9.99 4.37E-05 down
119901737 PREDICTED: hypothetical protein 4 6 20.4 18.24 0.02245 down
119904572 PREDICTED: hypothetical protein 3 0 6.15 4.95 0.01124 up
119884876 PREDICTED: hypothetical protein 3 2 9.65 2.72 0.03549 up
76631114 PREDICTED: hypothetical protein 35 15 106.7 81.25 0.02224 up
119923822 PREDICTED: hypothetical protein 63 51 205.06 170.94 0.001919 up
76644873 PREDICTED: hypothetical protein isoform 2 3 0 7.78 1.83 0.03381 up
76645752 PREDICTED: hypothetical protein isoform 4 1 4 1.62 9.68 0.003268 down
119912558 PREDICTED: hypothetical protein isoform 6 4 0 10.87 0 7.37E-12 up
119893872 PREDICTED: hypothetical protein LOC535130 5 1 14.93 12.61 0.03256 up
76687954 PREDICTED: hypothetical protein, partial 3 0 7.7 1.95 0.04264 up
119925886 PREDICTED: hypothetical protein, partial 3 0 6.76 5.69 0.01623 up
119895251 PREDICTED: profilin 3 2 4 12.89 19.46 0.01716 down
119922439 PREDICTED: similar to 1700016M24Rik protein 3 0 8.17 0 1.04E-04 up
119879571 PREDICTED: similar to AAT1-alpha 22 12 69.77 50.74 0.01412 up
119912554 PREDICTED: similar to Ace protein 15 4 55.74 20.29 8.69E-06 up
61878077 PREDICTED: similar to Actin-related protein T1 7 2 16.82 7.44 0.02775 up
119928361 PREDICTED: similar to ADAM metallopeptidase 7 2 23.85 10.3 0.01155 up
119913547 PREDICTED: similar to ADAM metallopeptidase with thrombospondin type 1 
motif, 17 preproprotein
5 0 12.58 0 1.24E-07 up
119903267 PREDICTED: similar to ALMS1 protein 4 0 10.2 2.89 0.02294 up
119892487 PREDICTED: similar to Ankyrin repeat domain-containing 1 3 1.88 7.82 0.03473 downBMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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76657564 PREDICTED: similar to calmodulin 10 5 23.53 16.83 0.04331 up
119901005 PREDICTED: similar to centrosomal protein 110kD 3 0 8.38 2.06 0.03921 up
119893858 PREDICTED: similar to chromosome 13 open reading 0 3 0 6.84 4.35E-04 down
61814552 PREDICTED: similar to Cytochrome c oxidase subunit 13 10 41.99 47.17 0.01639 up
119904416 PREDICTED: similar to diaphanous homolog 3 0 3 0 7.64 3.85E-04 down
119915202 PREDICTED: similar to DNAH8, partial 12 3 33.72 16.39 0.001961 up
119927503 PREDICTED: similar to DNAH8, partial 6 1 22.2 8.36 0.04519 up
119911633 PREDICTED: similar to EF-hand calcium binding domain 5 0 3 0 7.52 3.23E-05 down
119888835 PREDICTED: similar to EPH receptor A8 4 0 9.46 1.9 0.009866 up
119895747 PREDICTED: similar to FAT tumor suppressor 2 12 3 28.56 32.84 1.15E-04 up
119919673 PREDICTED: similar to ferritin L subunit isoform 1 4 0.57 10.42 3.74E-05 down
119909426 PREDICTED: similar to fertilin alpha 12 27 63.45 89.9 0.003791 down
119919953 PREDICTED: similar to filamin 0 3 0 6.94 4.54E-04 down
76662361 PREDICTED: similar to GFHL3075 isoform 3 3 0 8.3 7.63 0.01657 up
61820991 PREDICTED: similar to GK2 protein 16 9 54.86 31.79 0.01383 up
119901324 PREDICTED: similar to HECT domain and ankyrin repeat containing, E3 ubiquitin 
protein ligase 1 isoform 1
2 3 6.09 6.74 0.01418 down
119895512 PREDICTED: similar to HIST1H4I protein 3 0 6.36 1.06 0.007699 up
119915532 PREDICTED: similar to histone H2b-616 4 10 17.41 34.08 0.005828 down
76613952 PREDICTED: similar to histone H4 2 2 7.48 5.88 0.02561 down
76642199 PREDICTED: similar to Izumo sperm-egg fusion 1 39 24 133.67 99.29 0.005314 up
119890207 PREDICTED: similar to KIAA0191 18 26 70.99 64.29 0.01024 down
119891377 PREDICTED: similar to KIAA0225 isoform 1 1 4 1.01 9.43 5.50E-04 down
119890395 PREDICTED: similar to KIAA0467 protein 0 3 0 7.91 3.74E-06 down
119902048 PREDICTED: similar to KIAA1305 protein 0 3 0 7.91 0.001712 down
119906772 PREDICTED: similar to KIAA1429 protein isoform 0 3 0 6.98 4.55E-04 down
119912552 PREDICTED: similar to KIAA1636 protein 3 0 7.44 0 1.53E-04 up
119891313 PREDICTED: similar to KIAA1793 protein 12 8 52.91 37.11 0.0228 up
119909205 PREDICTED: similar to KIAA2017 protein isoform 6 0 17.51 6.69 0.01123 up
76664109 PREDICTED: similar to LOC505732 protein 4 6 14.08 12.97 0.01832 down
76641602 PREDICTED: similar to LOC507431 protein isoform 10 7 31.93 36.41 0.03413 up
119902010 PREDICTED: similar to LOC512571 protein 47 34 189.9 155.47 0.03649 up
119905900 PREDICTED: similar to NDRG3 0 3 0 7.3 1.80E-04 down
76612380 PREDICTED: similar to nestin 0 3 0 6.85 1.25E-04 down
119911939 PREDICTED: similar to netrin-1 2 4 2.84 8.74 0.01328 down
119894490 PREDICTED: similar to obscurin, cytoskeletal calmodulin and titin-interacting 
RhoGEF, partial
1 3 1.45 7.16 0.03376 down
119905455 PREDICTED: similar to Pitrilysin metallopeptidase 1 6 2.49 22.6 3.23E-05 down
76618065 PREDICTED: similar to Pou6f1 protein 4 1 15.92 11.31 0.006931 up
119894859 PREDICTED: similar to Protein KIAA1543 isoform 1 3 1.36 8.01 0.008488 down
119893105 PREDICTED: similar to protein kinase A binding protein 135 113 480.21 392.89 2.35E-05 up
76627105 PREDICTED: similar to RAB2B, member RAS oncogene 7 16 29.46 52.58 0.004367 down
119912290 PREDICTED: similar to RIKEN cDNA 4121402D02 3 0 7.29 0 2.00E-07 up
119914167 PREDICTED: similar to RIKEN cDNA A530050D06 gene 6 8 12.57 21.82 0.007372 down
119903563 PREDICTED: similar to RNA polymerase I polypept 3 6 7.15 15.59 0.03155 down
119910233 PREDICTED: similar to sca1 3 0 7.43 1.65 0.0301 up
119916698 PREDICTED: similar to Septin 12 0 3 0 8.2 2.26E-07 down
119903556 PREDICTED: similar to sulfotransferase K1 0 3 0 6.79 1.49E-04 down
119902145 PREDICTED: similar to telomerase-associated protein 3 0 8.27 0 8.45E-06 up
119914302 PREDICTED: similar to trans-Golgi p230 4 0 8.82 2.85 0.01983 up
119917225 PREDICTED: similar to TRRAP protein 2 5 2.92 11.86 0.002132 down
119917582 PREDICTED: similar to TUBA 3 1 9.42 3.39 0.03158 up
119912117 PREDICTED: similar to Tumor necrosis factor receptor 7 0 17.77 0 6.66E-12 up
119903686 PREDICTED: similar to ubiquitin specific protease 34 isoform1 1 4 2.31 9.99 0.01666 down
77736091 Prohibitin 7 3 22.59 9.08 0.03313 up
114052901 Rhabdoid tumor deletion region gene 1 10 2 31.71 15.41 0.009593 up
84000339 Sperm associated antigen 6 4 1 13.76 2.2 0.02495 up
87196516 Sperm mitochondria-associated cysteine-rich protein 3 0 9.82 3.51 0.03455 up
115495195 Tektin 1 27 19 107.5 76.3 0.0155 up
84000201 Transmembrane protein 5 3 1 6.27 6.97 0.004588 up
61888856 Triosephosphate isomerase 40 26 158.4 122.55 0.005981 up
27807143 Ubiquinol-cytochrome c reductase core protein II 7 2 33.24 16.14 0.02472 up
List of differentially expressed proteins in high fertility (HF) group spermatozoa when compared to low fertility group. (LF) spermatozoa In this table we provided 
the information about number of peptides, Sequest cross correlation (∑Xcorr) score and P value for each protein in high and low fertility group spermatozoa 
respectively.
Table 1: Differentially expressed proteins. (Continued)BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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metabolic pathways represented was comparable between
the low (8) and high (9) fertility spermatozoa. Epidermal
growth factor (EGF) signaling was the most prominent
signaling pathway specific to high fertility sperm (Figure
3). EGF signaling is known to promote proliferation, sur-
vival, and differentiation of a wide variety of mammalian
cells [23]. In addition to the EGF signaling pathway, plate-
let derived growth factor (PDGF) signaling, peroxisome
proliferated activator receptor (PPAR) signaling, inter-
leukin(IL) -4 signaling, NF-kβ signaling, chemokine sign-
aling, and insulin growth factor (IGF)-1 signaling were
identified only in high fertility spermatozoa. In low the
fertility group, Cell cycle: G2/M DNA damage check point
regulation was the most significant pathway followed by
integrin signaling.
Proteins with significantly altered expression: molecular 
network and pathway analysis
Systems analysis of global proteomes revealed that some
signaling pathways are differentially represented between
the high and low fertility group spermatozoa. To further
analyze these differentially expressed pathways, we car-
ried out IPA analysis with just the 125 differentially
expressed proteins. In high fertility spermatozoa, expres-
sion of 74 proteins was increased when compared to low
fertility spermatozoa. IPA analysis identified three signifi-
cant networks with scores of 22, 19, and 13 respectively.
Proteins identified in the top three networks are partici-
pants in EGF signaling, PDGF signaling, oxidative phoso-
phorylation, and pyruvate metabolism pathways.
Expression of two proteins, ATP synthase, H+ transport-
ing, mitochondrial F1 complex (ATP5B), and cytochrome
c oxidase subunit III (COX3) involved in oxidative phos-
phorylation and casein kinase II involved in EGF signaling
and PDGF signaling were higher in the high fertility sper-
matozoa compared to low fertility spermatozoa (Table 1).
IPA also identified pyruvate metabolism as the most sig-
Table 2: Top ten functions/diseases and their respective top ten signaling pathways in high fertility group spermatozoa.
Signaling Pathways






















Cell cycle 12 14 13 10 4 11 11 13 14 10




347 5 2 2 3 2 5 2
Cellular assembly and 
Organization
35 1 5 9 3 4 4 5 4 7
Cell morphology 15 17 31 10 6 10 15 16 14 12
Cardio-vascular disease 4 5 3 5 3 2 3 7 3 7
L i p i d  m e t a b o l i s m 222 2 1 2 2 3 2 2
Small molecule 
Biochemistry
91 0 1 2 1 2 1 6 8 9 1 21 2
Cell to cell signaling 
and interaction
68 2 2 3 1 3 3 5 6 7 7
Post translational 
modification
81 0 1 4 1 3 1 7 7 9 9 1 0
EGF: Epidermal Growth Factor; PDGF: Platelet Derived Growth Factor; IGF1: Insulin Growth Factor-1.
Overall effects in GO Slims of differentially expressed pro- teins of high and low fertility spermatozoa Figure 2
Overall effects in GO Slims of differentially expressed 
proteins of high and low fertility spermatozoa. Biolog-
ical process GO annotations of all significantly altered pro-
teins between high and low fertility spermatozoa were used 
to generate GO Slims. For each GO Slim, the difference in 
the numbers of proteins with increased expression and the 
number of proteins with decreased expression (relative to 
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nificant pathway in up regulated proteins of high fertility
spermatozoa. In the low fertility sperm proteome, expres-
sion of 51 proteins increased when compared to high fer-
tility spermatozoa. IPA analysis identified two significant
networks in highly expressed proteins of low fertility
sperm. Proteins identified in the top two significant net-
works are participants in integrin signaling and estrogen
receptor signaling.
Discussion
Male fertility can be described as the success by spermato-
zoa to fertilize oocytes and of the resulting zygotes con-
tinue on through embryonic and fetal development until
birth [11]. In this study we used bovine spermatozoa to
study fertility as it can serve as a model for understanding
human male infertility and reproductive diseases. Study-
ing Bovine male fertility on its own merit has implications
in agro-economics involving cattle industry worldwide.
A spermatozoon must reach the site of fertilization and be
capacitated for successful fertilization to occur. A subse-
quent step is the acrosome reaction characterized by
fusion of a spermatozoon outer acrosomal membrane
with overlying plasma membrane [8]. The molecular
mechanisms and signal transduction pathways mediating
the processes of capacitation and acrosome reaction have
been partially defined [8]. Bull sperm cytosolic fraction
proteomic analysis showed enrichment for tyrosine
kinases which are essential for phosphorylation of specific
sperm proteins during capacitation [24]. The abundance
of a variety of proteins from cells surrounding the sperm
has been proposed to indicate male fertility [2,14,15].
Most of the studies used 2-dimensional electrophoresis
(2-DE) for isolation and identification of sperm proteins
[13,25-28]. To our knowledge this is the first comprehen-
sive non-electrophoretic proteomic study of bull sperm
proteome. The aim of our study was to identify proteins
that were differentially expressed between high and low
fertility bull spermatozoa and interrelated metabolic and
signaling pathways that have a role in fertility.
We identified 125 proteins as differentially expressed in
between the high and low fertility sperm even though
1518 proteins were common to both groups and about
2000 were unique to each. The reasons for this apparent
discrepancy are that we took a conservative approach to
the statistical analysis: only proteins identified by at least
three peptides were included in the analysis for differen-
tial expression and the statistical method used in Prot-
Quant is very conservative. ProtQuant specifically address
the issue of "missing" mass spectra that occurs in all 2-D
LC MS2 -based expression proteomics methods. No other
published method (either non-isotopic or isotopic)
addresses this issue. Missing mass spectra are due to the
inherent limitations of the mass spectrometers, the prob-
abilistic nature of sampling and the cutoffs used to deter-
mine "true" assignments of peptides to mass spectra [29].
ProtQuant is highly conservative method which is based
on sum of Xcorr method itself increases the specificity of
spectral counting and reduce the type I errors of differen-
tial expression. Regardless, proteins were analyzed from
each of three of the areas represented in Figure 1 and dif-
ferentially-expressed proteins occurred in all three (i.e.






























1.Cell cycle 10 11 11 10 5 8 8 10 10 7
2.Cell morphology 3 26 13 18 7 11 18 14 31 26
3.Post translational 
modification
9 12 9 11 9 5 11 9 14 11
4.Cellular assembly 
and Organization
3 18 4 10 5 5 7 4 23 20
5.Lipid metabolism 0 2 3 5 5 3 5 2 2 4
6.Small molecule 
biochemistry
5 9 10 11 8 4 13 7 11 11
7.Connective 
tissue disorder
1 12 1 11 2 4 10 6 11 1
8.Gene Expression 8 6 8 16 6 5 16 11 6 8
9.Cell death 7 17 14 17 8 8 14 13 15 18
10.Reproductive 
system disease
9 5 6 9 2 7 4 8 14 12
MAPK: Mitogen Activated Protein Kinase; VEGF: Vascular Endothelial Growth Factor; PTEN: Phosphatase and tensin homolog deleted on chromosome 
ten.BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
Page 8 of 14
(page number not for citation purposes)
proteins unique to the high and low fertility sperm as well
as those common to both).
From proteome profiles of specific cells or tissues, one
acquires large datasets that are inherently complex. As a
result we consider it beneficial to model our bovine sperm
proteome data sets using GO and IPA. From GO associa-
tions of differentially expressed proteins we found that
there was a comparative up regulation of three biological
processes in high fertility spermatozoa: metabolism, cell
communication and cell motility (Fig 2).
Up regulation of metabolism is consistent with the fact
that capacitation is coupled to a specific type of metabo-
lism, that is glycolysis or oxidative respiration [30]. Pyru-
vate metabolism and glycolysis were the top most
significant metabolic pathways represented in high fertil-
ity sperm proteome by IPA. In glycolysis, expression of
pyruvate kinase (PKM2) was higher in high fertility sper-
matozoa. PKM2 catalyzes the production of pyruvate and
ATP from phosphoenol pyruvate. Pyruvate formed in this
process serves as an energy source for cells [31]. Impaired
or lower pyruvate metabolism could limit the cell's ability
to produce energy and this could be one of the reasons for
reduced fertility in the low fertility group.
Expression of COX 3 and ATP5B involved in oxidative res-
piration was higher in high fertility spermatozoa com-
pared to low fertility spermatozoa. COX3 is a member of
the large transmembrane protein complex found in the
mitochondrion and is the last protein in the electron
transport chain. Coupling of electron transport to oxida-
tive respiration maintains the high mitochondrial trans-
membrane potential required for mitochondrial ATP
production [32]. ATP5B catalyzes the production of ATP
from ADP in the presence of a proton gradient across the
mitochondrial membrane and this ATP is utilized for the
motility of sperm and capacitation [33].
EGF signaling pathway generated by the Ingenuity Pathway Analysis (IPA) software Figure 3
EGF signaling pathway generated by the Ingenuity Pathway Analysis (IPA) software. EGF and PDGF signaling path-
ways were the top two pathways in the top 10 functions/diseases associated with the high fertility spermatozoa (Table 2). Each 
node represents a protein; proteins in shaded nodes were found in the high fertility spermatozoa dataset (see additional file 1) 
while proteins in clear nodes were not found in the high fertility spermatozoa dataset.BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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Communication between sperm and oocyte is critical for
successful fertilization. We found that there was up regu-
lation of cell communication in the high fertility sperm
proteome when compared to low fertility sperm pro-
teome (Figure 2). To bring about cell to cell communica-
tion several signaling pathways are necessary. EGF
signaling and PDGF signaling were the top two significant
signaling pathways identified in high fertiliy spermato-
zoa. EGF and PDGF signaling pathways stimulate tyrosine
phosphorylation of various MAP kinases and their
upstream activators MEK1, MEK2 and MEKK [34,35]. EGF
signaling has an important role in sperm capacitation as it
stimulates tyrosine phosphorylation of many proteins
[36]. In addition, EGF signaling also activates phospholi-
pase C (PLC) [36] (Figure 3). PLC is important for the
acrosome reaction (AR), fertilization and embryo devel-
opment. PLC catalyzes the production of inositol 1, 4, 5-
triphosphate (IP3) from phosphatidylinositol 4, 5-
biphosphate. IP3 generated by PLC activates the extra cel-
lular calcium influx required for the AR via binding to the
IP3 receptor (IP3R) gated calcium channel located on the
acrosome membrane [37]. Mutations in mouse PLCB1
reduced the AR rate, fertilization rate and embryo devel-
opment [38]. EGF signaling was specific to high fertility
bull sperm. Defects in EGF signaling in low fertility sper-
matozoa may prevent capacitation.
Expression of casein kinase 2 (CKII) prime poly peptide in
EGF signaling was higher in high fertility spermatozoa
compared to low fertility spermatozoa (Table 1). CKII is
preferentially expressed in late stages of spermatogeneis
and is involved in sperm chromatin decondensation after
sperm oocyte fusion [39,40]. CKII deficient mice are infer-
tile with oligospermia and globozoospermia[40]. EGF sig-
naling also induces actin polymerization in bovine sperm
capcitation [41]. Actin polymerization is essential for
incorporation of sperm into egg cytoplasm [42] and for
sperm nuclei decondensation [43].
Comparing the proteome profiles of bull sperm of high
and low fertility showed some molecular features associ-
ated with low fertility. Cell cycle: G2/M DNA damage
check point regulation was the topmost significant signal-
ing pathway followed by integrin signaling in low fertility
bull sperm (Table 3). The G2/M DNA damage checkpoint
could help in maintaining the integrity of the genome
during different stages of development. Progression
through different phases of the cell cycle requires the
sequential activation of various cyclin dependent kinases
and these kinases in turn are regulated by integrin signal-
ing. Integrin signals are necessary for cells to traverse the
cell division cycle [44]. These two pathways may be a
compensatory response for reproductive system disease
function which was identified only in low fertility sperm
(Table 3).
In addition to differences in signaling and metabolic
pathways between high and low fertility spermatozoa, we
identified differences in protein expression that had
implications in sperm motility. Expression of A-kinase
anchor protein-4 (AKAP4) was significantly higher in high
fertility spermatozoa (Table 1). AKAP4 is a major fibrous
sheath protein of the principal piece of the sperm flagel-
lum. AKAP4 recruits Protein kinase A to the fibrous sheath
and facilitates local phosphorylation to regulate flagellar
function in humans [45]. It also serves as a scaffolding
protein for signaling proteins and proteins involved in
metabolism. Higher expression of AKAP4 in the high fer-
tility group sperm could result in higher motility.
Conclusion
In summary, this is the first comprehensive description of
the spermatozoa proteome of bovine. Comparative pro-
teomic analysis of high fertility and low fertility bulls, in
the context of protein interaction networks identified
putative molecular markers associated with high fertility
phenotype. We observed marked differences in signaling
and metabolic pathways between high fertility and low
fertility spermatozoa that have implications in sperm
capacitation, acrosomal reaction and sperm-oocyte com-
munication.
Methods
Selection of high and low fertility bulls
Frozen semen samples and bull fertility data (see addi-
tional file 2) from six mature and progeny tested Holstein
bulls with satisfactory semen quality were provided by
Alta Genetics (Watertown, WI).
Sample and Data Sources
The fertility data were established by a progeny testing
program named Alta Advantage®, which is the industry's
most reliable source of fertility information. It consisted
of insemination records collected from 180 well managed
partner dairy farms located in different geographical
regions across the United States. This breeding program
provided the advantages of DNA verification of the pater-
nity of the offspring, and diagnosed pregnancies by veter-
inary palpation, instead of just relying on non-return rates
60–90 days after breeding.
Bull Fertility Prediction
To predict fertility of the bulls from the given source, a
sub-set of data were generated consisting of 962,135
insemination records from 934 bulls with an average of
1,030 breedings ranging from 300 to 15,194. The environ-
mental and herd management factors that influence fertil-
ity performance of sires were adjusted using threshold
models which were similar to previously published mod-
els by Zwald et al [46,47]. Parameters estimation and fer-BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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tility prediction were obtained using Probit.F90 software
developed by Y. M. Chang [48].
Therefore, for the definition of fertility, instead of relying
only on the number of pregnant cows (verified using pal-
pation by a veterinarian or ultrasound examination)
divided by the total number of cows examined for preg-
nancy, we considered the outcome of each breeding event
and adjusted the environmental factors such as the effects
of herd-year-month, parity, cow, days in milk, sire proven
status (young, proven, colored) in order to rank the bulls
based on their breeding values for fertility. Further, the fer-
tility of each bull was calculated and expressed as the per-
cent deviation of its conception from the average
conception of all bulls having at least 300 breeding in the
data set.
Selection of high and low fertility bulls
For this study, we used an arbitrary threshold for classify-
ing high and low fertility bulls. However, the bulls scoring
highest and lowest fertility deviation from average with
highest reliability (>1,000 breeding/bull) were selected
for this study. The differences in the average fertility
indexes between high and low fertility groups were 5.46%
which was obtained from bulls having adequate records
for higher reliability. While three bulls which were scored
5.3% above the average were considered high fertile, three
bulls which were scored 10.76% below the average were
defined as low fertility (see additional file 2). Two sepa-
rated pools of sperm cells (3 × 108) were constituted by
mixing equal amounts of sperm cells from either three
low or three high fertility bulls. The experiment was repli-
cated three times.
Isolation of pure sperm cells
Spermatozoa were collected from high and low fertility
bulls and frozen in 0.25 ml straws. For each bull, the total
spermatozoa collected were purified by Percoll gradient
centrifugation: 90% Percoll solution in water was pre-
pared with DL-Lactate (19 μM), CaCl2 (2 μM), NaHCO3
(25 mM), MgCl2 (400 μM), KCl (3 μM), NaH2PO4 (310
μM), NaCl (2 mM) and Hepes (10 mM). 90% Percoll
solution was diluted to 45% with sperm diluent medium
(1 mM pyruvate, 10 mM Hepes, 0.021 mM DL-Lactate in
Tyrode's salt solution, pH 7.4). A density gradient of Per-
coll was prepared in an Eppendorf tube (0.1 ml of 90%
fraction under 1 ml of the 45% fraction). Spermatozoa
were thawed at 35°C for 1 min and layered on top of the
percoll gradient. The spermatozoa were pelleted by cen-
trifugation (956 g; 15 min) followed by two washes in
phosphate-buffered solution (PBS) (956 g; 5 min,). The
total sperm count was obtained using an Improved Neu-
bauer Hemacytometer and 108 sperm cells were aliquoted
and stored at -80°C.
Protein extraction by DDF
DDF sequentially extracts proteins from different cellular
compartments using a series of detergents and this off-line
pre-fractionation step in sample preparation increases the
proteome coverage. Another advantage of using DDF is
that based on the DDF fractions from which proteins are
identified, proteins can be found in different cellular loca-
tions. Proteins were isolated using DDF as previously
described [18]. Cytosolic proteins were extracted by six
sequential incubations in a buffer containing digitonin
(10 min each); next a fraction containing predominantly
membrane proteins was isolated by incubating the cells in
10% Triton X-100 buffer for 30 min and then removing
the soluble protein. Nuclear DDF buffer containing deox-
ycholate (DOC) was then added to the remaining insolu-
ble material and subjected to freeze-thawing to disrupt the
nucleus. Nuclear proteins were collected from the result-
ing soluble fraction and the sample was then aspirated
through an 18 g needle and treated with a mixture of
DNase I (50U, Invitrogen, Carlsbad CA;) and RNase A (50
mg; Sigma-Aldrich, St Louis, MO) at 37°C for 1 h) to
digest nucleic acids. Any remaining pellet, containing the
least soluble proteins, was treated with a buffer containing
5% SDS.
Proteomics
Proteomic analysis was carried out with triplicate samples
of spermatozoa from the high fertility group and low fer-
tility group spermatozoa as described [19]. Proteins were
precipitated with 25% tricholoroacetic acid to remove
salts and detergents. Protein pellets were resuspended in
0.1 M ammonium bicarbonate with 5% HPLC grade ace-
tonitrile (ACN), reduced (5 mM, 65°C, 5 min), alkylated
(iodoacetamide, 10 mM, 30°C, 30 min) and then trypsin
digested until there was no visible pellet (sequencing
grade modified trypsin, Promega; 1:50 w/w 37°C, 16 h).
Peptides were desalted using a peptide macrotrap
(Michrom BioResources, Inc., Auburn, CA) and eluted
using a 0.1% trifluoroacetic acid, 95% ACN solution.
Desalted peptides were dried in a vacuum centrifuge and
resuspended in 20 μL of 0.1% formic acid and 5% ACN.
LC analysis was accomplished by strong cation
exchange(SCX) followed by reverse phase liquid chroma-
tography (RP-LC) coupled directly in line with an ESI ion
trap mass spectrometer (LCQ Deca XP Plus; ThermoElec-
tron Corporation; San Jose, CA). Samples were loaded
into a LC gradient ion exchange system (Thermo Separa-
tions P4000 quaternary gradient pump coupled with a
0.32 × 100 mm BioBasic strong cation exchange column).
A flow rate of 3 μL/min was used for both SCX and RP col-
umns.
A salt gradient was applied in steps of 0, 10, 15, 20, 25, 30,
35, 40, 45, 50, 57, 64, 90, and 700 mM ammonium ace-
tate in 5% ACN, 0.1% formic acid, and the resultant pep-BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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tides were loaded directly into the sample loop of a 0.18
× 100 mm BioBasic C18 reverse phase liquid chromatog-
raphy column of a Proteome X workstation (ThermoElec-
tron). The reverse phase gradient used 0.1% formic acid in
ACN and increased the ACN concentration in a linear gra-
dient from 5% to 30% in 20 min and then 30% to 95% in
7 min, followed by 5% for 10 min for 0, 10, 15, 25, 30,
45, 64, 90, and 700 mM salt gradient steps. For 20, 35, 40,
50 and 57 mM salt gradient steps ACN concentration was
increased in a linear gradient from 5% to 40% in 65 min
95% for 15 min and 5% for 20 min.
The mass spectrometer was configured to optimize the
duty cycle length with the quality of data acquired by
alternating between a single full MS scan followed by
three tandem MS scans on the three most intense precur-
sor masses (as determined by Xcalibur software in real
time) from the full scan. The collision energy was normal-
ized to 35%. Dynamic mass exclusion windows were set
at 2 min, and all of the spectra were measured with an
overall mass/charge (m/z) ratio range of 300–1700.
All searches were done using TurboSEQUEST™ (Bioworks
Browser 3.2; ThermoElectron). Mass spectra and tandem
mass spectra were searched against an in silico trypsin-
digested database of bovine RefSeq proteins downloaded
from the National Center for Biotechnology Institute
[NCBI; 12/26/2006; 24,853 entries]. Trypsin digestion
including mass changes due to cysteine carbamidometh-
ylation (C, 57.02 Da) and methionine mono- and di-oxi-
dation (15.99 Da and 32 Da), was included in the search
criteria. The peptide (MS precursor ion) mass tolerance
was set to 1.5 Da and the fragment ion (MS2) mass toler-
ance was set to 1.0 Da. Rsp Value less than 5.
As a primary filter we first limited our Sequest search out-
put to include only peptides ≥ 6 amino acids long, with
ΔCn ≥ 0.08 and Sequest cross correlation (Xcorr) scores of
1.5, 2.0 and 2.5 for +1, +2, and +3 charge states, respec-
tively. We next used a decoy database search strategy [49]
(using the same primary filter for the real database search)
to calculate P values for peptide identifications as this
allows us to assign the probability of a false identification
based on the real data from the experiment itself [49-52].
Since the accuracy of peptide identification depends on
the charge state we calculated P values for +1, +2, and +3
charge states separately. The probability that peptide iden-
tification from the original database is really a random
match (P value) is estimated based on the probability that
a match against the decoy database will achieve the same
Xcorr [51,53]. Protein probabilities were calculated
exactly as described [54,55] using only peptides with a P
< 0.05 and only those proteins were used for further mod-
eling. All protein identifications and their associated MS
data have been submitted to the PRoteomics IDEntifica-
tions database (PRIDE ;[56]) and PRIDE accession num-
bers are 1883–1888.
Differential protein expression
Label free quantification approaches design to quantify
relative protein abundances directly from high through-
put proteomic analyses with out labeling techniques.
Here, we used ProtQuant [29], a java based tool for label
free quantification that uses a spectral counting method
with increased specificity (and thus decreased false posi-
tive i.e. type I errors). This increased specificity is achieved
by incorporating the quantitative aspects of the Sequest
cross correlation (XCorr) into the spectral counting
method. ProtQuant also computes the statistical signifi-
cance of differential expression of control and treatment
for each protein using one-way ANOVA (α ≤ 0.05). This
method requires at least 3 peptides for each protein from
the combination of the control and treatment before to
calculate a p-value.
Gene Ontology Annotation
We used Gene Ontology (GO) resources and tools availa-
ble at AgBase [57] to identify the molecular functions and
biological processes represented in differentially
expressed proteins in our datasets. We used GORetriver
tool to obtain all existing GO annotations available for
known proteins in our datasets. We first GO-annotated
differentially expressed proteins in our datasets using
existing annotations from probable orthologs with ≥90%
sequence identity using the UniRef 90 database. Proteins
without annotation at UniRef 90, but between 70–90%
sequence identities to presumptive orthologs with GO
annotation were GO-annotated using GOanna tool [22].
Biological process annotations for these proteins were
grouped into more generalized categories using GOSlim
viewer [22].
Modeling using Ingenuity pathway analysis
To gain insights into the biological pathways and net-
works that are significantly represented in our proteomic
datasets we used Ingenuity Pathways Analysis (IPA; Inge-
nuity Systems, California). Currently IPA accepts gene/
protein accession numbers from human, mouse, and rats
only. Therefore, to use IPA, we mapped bovine proteins
from our datasets to their corresponding human
orthologs by identifying reciprocal-best-BLAST hits and
uploaded these accession numbers into IPA. IPA selects
"focus genes" to be used for generating biological net-
works. Focus genes are based on proteins from our data-
sets that are mapped to corresponding gene objects in the
Ingenuity Pathways Knowledgebase (IPKB) and are
known to interact with other genes based on published,
peer reviewed content in the IPKB. Based on these interac-
tions IPA builds networks with a size of no more than 35
genes or proteins. A P-value for each network and canon-BMC Systems Biology 2008, 2:19 http://www.biomedcentral.com/1752-0509/2/19
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ical pathway is calculated according to the fit of the user's
set of significant genes/proteins. IPA computes a score for
each network from P-value and indicates the likelihood of
the focus genes in a network being found together due to
chance. We selected networks scoring ≥ 2, which have >
99% confidence of not being generated by chance [58,59].
Biological functions are assigned to each network by using
annotations from scientific literature and stored in the
IPKB. Fisher exact test is used to calculate the P-value
determining the probability of each biological function/
disease or pathway being assigned by chance. We used P ≤
0.05 to select highly significant biological functions and
pathways represented in our proteomic datasets [58].
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